Professional Overview
Keith McBride is a seasoned executive in the medical technology industry, currently serving as Chief Technology Officer Vice President of R&D Pain and Restorative Therapies at Bioventus. His key expertise areas include research and development, pain management, and restorative therapies, with a strong focus on the healthcare industry.
Experience Summary
Current Role
As Chief Technology Officer Vice President of R&D Pain and Restorative Therapies at Bioventus, Keith is responsible for driving innovation and growth through research and development initiatives. His key responsibilities include leading cross-functional teams, developing strategic plans, and overseeing the execution of projects. During his tenure, he has made significant contributions to the development of new products and technologies, resulting in improved patient outcomes and increased market share.
Career Progression
Keith's career trajectory spans over two decades, with notable previous roles including Chief Technology Officer at Bioness Inc (Alfred Mann), Executive Vice President of Marketing and Product Development, and Director of Clinical Affairs and Education. He has also held academic positions as an Adjunct Professor and Assistant Professor at the University of Maryland School of Medicine. Throughout his career, Keith has demonstrated a strong ability to lead teams, drive innovation, and achieve results.
Academic Background
Although the highest level of education is not specified, Keith has held various academic positions, including Adjunct Professor and Assistant Professor at the University of Maryland School of Medicine. His relevant specializations and notable academic achievements are not provided.
Areas of Expertise
Keith's industry-specific skills include research and development, product innovation, and regulatory compliance. His technical competencies encompass medical technology, pain management, and restorative therapies. As a seasoned executive, he possesses strong leadership and management capabilities, with expertise in strategic planning, team management, and project execution.
Professional Impact
Keith has made significant contributions to the medical technology industry through his work on various projects and initiatives. Although specific details are not provided, his achievements have likely resulted in improved patient outcomes, increased market share, and growth for his organizations.
Conclusion
Throughout his career, Keith has demonstrated a strong commitment to innovation, leadership, and results-driven performance. As a seasoned executive in the medical technology industry, he brings a unique combination of technical expertise, business acumen, and leadership capabilities to his current role as Chief Technology Officer Vice President of R&D Pain and Restorative Therapies at Bioventus. His value proposition lies in his ability to drive growth, innovation, and success in the healthcare industry.
